Daftar ini didasarkan pada daftar pantauan pengguna Stock Events yang mengikuti TQ8.MU. Ini bukan rekomendasi investasi.
Daftar ini adalah analisis berdasarkan peristiwa pasar terbaru. Ini bukan rekomendasi investasi.
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH1902, which is in Phase 1/Part A clinical trials for the treatment of triple negative breast cancer; and TH1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.
Show more...
FAQ
Apa simbol saham Theratechnologies?▼
Tergantung pada bursa, simbol saham dapat berbeda. Misalnya, di bursa , saham Theratechnologies diperdagangkan dengan simbol TQ8.MU.
Berapa jumlah karyawan Theratechnologies?▼
Per Juli 08, 2026, perusahaan memiliki 103 karyawan.
Theratechnologies berada di sektor apa?▼
Theratechnologies beroperasi di sektor Kesehatan & Kebugaran.
Kapan Theratechnologies menyelesaikan split saham?▼
Theratechnologies belum melakukan split saham baru-baru ini.
Di mana kantor pusat Theratechnologies?▼
Kantor pusat Theratechnologies berlokasi di Montreal, Kanada.